Upregulated NLRP3 inflammasome activation is attenuated by anthocyanins in patients with nonalcoholic fatty liver disease: A case-control and an intervention study
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Upregulated NLRP3 inflammasome activation is attenuated by anthocyanins in patients with nonalcoholic fatty liver disease: A case-control and an intervention study
Authors
Keywords
Anthocyanin, Inflammasome, Nonalcoholic fatty liver disease, Peripheral blood mononuclear cells
Journal
Clinics and Research in Hepatology and Gastroenterology
Volume 46, Issue 4, Pages 101843
Publisher
Elsevier BV
Online
2021-12-16
DOI
10.1016/j.clinre.2021.101843
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pathogenetic mechanisms of nonalcoholic fatty liver disease and inhibition of the inflammasome as a new therapeutic target
- (2021) Yasar Colak et al. Clinics and Research in Hepatology and Gastroenterology
- Long‐term outcomes of non‐alcoholic fatty liver disease and the risk factors for mortality and hepatocellular carcinoma in a Japanese population
- (2020) Tomomi Kogiso et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- A dose-response evaluation of purified anthocyanins on inflammatory and oxidative biomarkers and metabolic risk factors in healthy young adults: A randomized controlled trial
- (2020) Yi Guo et al. NUTRITION
- Anthocyanin supplementation improves anti-oxidative and anti-inflammatory capacity in a dose–response manner in subjects with dyslipidemia
- (2020) Hanyue Zhang et al. Redox Biology
- FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study
- (2020) Philip N Newsome et al. Lancet Gastroenterology & Hepatology
- Anthocyanin supplementation at different doses improves cholesterol efflux capacity in subjects with dyslipidemia—a randomized controlled trial
- (2020) Zhongliang Xu et al. EUROPEAN JOURNAL OF CLINICAL NUTRITION
- Inhibitory effects of phytochemicals on NLRP3 inflammasome activation: A review
- (2020) Melis Olcum et al. PHYTOMEDICINE
- Synthetic vitamin K analogs inhibit inflammation by targeting the NLRP3 inflammasome
- (2020) Xicui Zheng et al. Cellular & Molecular Immunology
- Inhibition of Interleukin-1β and Reduction in Atherothrombotic Cardiovascular Events in the CANTOS Trial
- (2020) Brendan M. Everett et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The selective NLRP3 inflammasome inhibitor MCC950 alleviates cholestatic liver injury and fibrosis in mice
- (2019) Junwen Qu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- The antiobesity effects of anthocyanins on mitochondrial biogenesis, inflammation and oxidative stress: A systematic review
- (2019) Gomes Jaqueline Vieira Piovezana et al. NUTRITION
- Obesity-related inflammatory modulation by juçara berry (Euterpe edulis Mart.) supplementation in Brazilian adults: a double-blind randomized controlled trial
- (2019) Aline Boveto Santamarina et al. EUROPEAN JOURNAL OF NUTRITION
- Anthocyanins ameliorate palmitate‐induced inflammation and insulin resistance in 3T3‐L1 adipocytes
- (2019) Claudia Muscarà et al. PHYTOTHERAPY RESEARCH
- Anthocyanin supplementation inhibits secretion of pro-inflammatory cytokines in overweight and obese individuals
- (2019) Lada Vugic et al. Journal of Functional Foods
- Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
- (2018) Zobair M. Younossi et al. HEPATOLOGY
- Anthocyanin-Rich Extract from Red Chinese Cabbage Alleviates Vascular Inflammation in Endothelial Cells and Apo E−/− Mice
- (2018) Hee Joo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice
- (2018) Bing Xu et al. JOURNAL OF HEPATOLOGY
- Red raspberries suppress NLRP3 inflammasome and attenuate metabolic abnormalities in diet-induced obese mice
- (2018) Mei-Jun Zhu et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Global Perspectives on Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis
- (2018) Zobair Younossi et al. HEPATOLOGY
- Anthocyanins As Modulators of Cell Redox-Dependent Pathways in Non-Communicable Diseases
- (2018) Antonio Speciale et al. CURRENT MEDICINAL CHEMISTRY
- NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice
- (2017) Auvro R. Mridha et al. JOURNAL OF HEPATOLOGY
- Black soybean anthocyanins attenuate inflammatory responses by suppressing reactive oxygen species production and mitogen activated protein kinases signaling in lipopolysaccharide-stimulated macrophages
- (2017) Jin Nam Kim et al. Nutrition Research and Practice
- Role of Purified Anthocyanins in Improving Cardiometabolic Risk Factors in Chinese Men and Women with Prediabetes or Early Untreated Diabetes—A Randomized Controlled Trial
- (2017) Liping Yang et al. Nutrients
- Differences in metabolic biomarkers in the blood and gene expression profiles of peripheral blood mononuclear cells among normal weight, mildly obese and moderately obese subjects
- (2016) Un Ju Jung et al. BRITISH JOURNAL OF NUTRITION
- Fish-oil-derived n-3 polyunsaturated fatty acids reduce NLRP3 inflammasome activity and obesity-related inflammatory cross-talk between adipocytes and CD11b+ macrophages
- (2016) Anna A. De Boer et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Chemistry, Pharmacology and Health Benefits of Anthocyanins
- (2016) Antonella Smeriglio et al. PHYTOTHERAPY RESEARCH
- Role of NLRP3 Inflammasome in the Progression of NAFLD to NASH
- (2016) Xingyong Wan et al. Canadian Journal of Gastroenterology and Hepatology
- A CONSORT-Compliant, Randomized, Double-Blind, Placebo-Controlled Pilot Trial of Purified Anthocyanin in Patients With Nonalcoholic Fatty Liver Disease
- (2015) Pei-Wen Zhang et al. MEDICINE
- ZJU index: a novel model for predicting nonalcoholic fatty liver disease in a Chinese population
- (2015) Jinghua Wang et al. Scientific Reports
- NLRP3 inflammasome activation is required for fibrosis development in NAFLD
- (2014) Alexander Wree et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice
- (2013) Alexander Wree et al. HEPATOLOGY
- Upregulated NLRP3 Inflammasome Activation in Patients With Type 2 Diabetes
- (2012) Hye-Mi Lee et al. DIABETES
- Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
- (2012) Jorge Henao-Mejia et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search